Cibc World Market Inc. Aurinia Pharmaceuticals Inc. Transaction History

Cibc World Market Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$10.93 - $23.55 $207,484 - $447,049	-18,983 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$10.0 - $14.52 $48,520 - $70,451	4,852 Added 34.34%	18,983 $246,000
Q1 2021 May 11, 2021	BUY	$12.3 - $18.73 $18,536 - $28,226	1,507 Added 11.94%	14,131 $183,000
Q4 2020 Feb 08, 2021	SELL	$12.94 - $16.05 $48,046 - $59,593	-3,713 Reduced 22.73%	12,624 $175,000
Q3 2020 Nov 12, 2020	BUY	$13.19 - $16.66 $17,331 - $21,891	1,314 Added 8.75%	16,337 $241,000
Q2 2020 Aug 13, 2020	BUY	$14.12 - $18.33 $212,124 - $275,371	15,023 New	15,023 $244,000

210

58.1M

1.14M

1.51M

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.13B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Cibc World Market Inc., based on Form 13F filings with the SEC.

Stay updated on Cibc World Market Inc. with notifications on news.